SeaStar Medical to Hold Business Update Conference Call on December 11, 2024
SeaStar Medical to Hold Business Update Conference Call on December 11, 2024
DENVER, Dec. 04, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs, announces that management will hold a conference call to discuss business progress and updates.
丹佛，2024年12月04日（环球新闻）-- SeaStar医疗控股公司（纳斯达克：ICU），一家处于商业阶段的医疗器械公司，正在开发专有解决方案以减少超炎症对重要器官的影响，管理层宣布将举行一次电话会议，讨论业务进展和更新。
| Date/Time: | Wednesday, December 11, 4:30 p.m. ET / 1:30 p.m. PT |
| Pre-Registration: | Participants can pre-register for the conference call here: |
| Callers who pre-register will be given a conference passcode and unique PIN to gain immediate access to the call and bypass the live operator. Participants may pre-register at any time, including up to and after the call start time. | |
| Dial In: | Those who choose not to pre-register can access the live conference call by dialing the following and requesting the SeaStar Medical call: |
| 866-777-2509 within the U.S. | |
| 412-317-5413 from outside the U.S. |
| 日期/时间： | 2023年12月11日，下午4:30 ET / 下午1:30 PT |
| 预注册： | 参与者可以在这里预注册电话会议： |
| 预先注册的来电者将获得会议通行码和唯一的PIN码，以便立即访问电话并绕过实时运营商-5G。参与者可以在任何时间进行预注册，包括在电话开始时间之前和之后。 | |
| 拨打： | 选择不提前注册的人可以拨打以下电话以访问实时会议电话，并请求SeaStar Medical的电话： |
| 在美国拨打866-777-2509。 | |
| 从美国以外拨打412-317-5413。 |
The live webcast of the conference call also will be available here. A replay of the call will be available for 48 hours beginning two hours after its completion by dialing 877-344-7529 from within the U.S., 855-669-9658 from Canada or 412-317-0088 from outside the U.S., and entering conference ID 3855739. The webcast will also be archived here.
会议电话的直播网络广播将在此处提供。电话重播将在会议结束后两小时内提供，为期48小时，拨打877-344-7529（美国境内），855-669-9658（加拿大）或412-317-0088（美国境外），并输入会议ID 3855739。此处也将存档网络广播。
About SeaStar Medical
SeaStar Medical is a commercial-stage medical technology company that is redefining how extracorporeal therapies may reduce the consequences of excessive inflammation on vital organs. SeaStar Medical's novel technologies rely on science and innovation to provide life-saving solutions to critically ill patients. The Company is developing and commercializing cell-directed extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. For more information visit or visit us on LinkedIn or X.
关于SeaStar Medical
SeaStar Medical是一家商业阶段的医疗科技公司，正在重新定义体外治疗如何减少过度炎症对重要器官的影响。SeaStar Medical的创新技术依赖于科学和创新，为危重病患者提供救命解决方案。公司正在开发和商业化以细胞为导向的体外疗法，针对导致全身炎症的效应细胞，这些细胞会造成直接的组织损伤，并分泌一系列促炎症细胞因子，启动并传播失衡的免疫反应。欲了解更多信息，请访问或在LinkedIn或X上关注我们。
Contact:
联系：
Alliance Advisors IR
Jody Cain
(310) 691-7100
Jcain@allianceadvisors.com
联盟顾问投资者关系
乔迪·凯恩
(310) 691-7100
Jcain@allianceadvisors.com
# # #
# # #
